Detalhe da pesquisa
1.
Neuroleptic malignant syndrome: evaluation of drug safety data from the AMSP program during 1993-2015.
Eur Arch Psychiatry Clin Neurosci
; 270(1): 23-33, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30506147